Correction: Comment on 'The Post-Finasteride Syndrome: Possible Etiological Mechanisms and Symptoms'

The correction addresses a conflict of interest in the original article on post-finasteride syndrome. Initially, it was stated that the author had no competing interests. However, it was later disclosed that the author is a member of the editorial board of IJIR: Your Sexual Medicine Journal and had previously served as a consultant for a law firm representing Merck & Co, Inc., the manufacturer of Propecia. Additionally, the author attended an advisory summit and is listed as a "Medical Advisor" on the summit's website. The original article has been updated to reflect these disclosures.